COMPANY PROFILE // THE 014 REPORT
MindMaze Therapeutics Holding SA
MMTZF (OTC) · RLFTY (OTC) · Formerly: Relief Therapeutics Holding SA; Relief Therapeutics Holding AG
Assembled from 1 government source in 0.3 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- AmberNo 10-K, 10-Q, 20-F or 40-F since 2024-04-30 (20-F, about 31 months): an active periodic filer has stopped filing.
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
MindMaze Therapeutics Holding SA is an SEC-registered company in pharmaceutical preparations, based in Ch-1202 Geneva; listed as MMTZF (OTC), RLFTY (OTC).[source] It has filed 1 documents with the SEC in the last 12 months; the latest is Form 424B3, filed 2026-04-16.[source] Seraphix flags 1 item from these records: No 10-K, 10-Q, 20-F or 40-F since 2024-04-30 (20-F, about 31 months).[source]
- red0
- amber1
- info0
- CLEAR26
- POSSIBLE MATCH0
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0001854078 | source |
| EIN | 00-0000000 | source |
| Business address (SEC) | AVENUE DE SECHERON 15, CH-1202 GENEVA | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-04-30 · in 161 days · Next 20-F due (period ended 2026-12-31; Non-accelerated filer<br>Emerging growth company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2834 (pharmaceutical preparations): 568 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- PFIZER INC · 124 SEC filings in 12 months · $25.74B federal (possible match)
- Merck & Co., Inc. · 150 SEC filings in 12 months · $13.51B federal (possible match)
- ABBOTT LABORATORIES · 118 SEC filings in 12 months · 1 flag · $2.64B federal (possible match)
- ASTRAZENECA PLC · 140 SEC filings in 12 months · $602.8M federal (possible match)
- TEVA PHARMACEUTICAL INDUSTRIES LTD · 168 SEC filings in 12 months · $77.6M federal (possible match)
- NOVARTIS AG · 34 SEC filings in 12 months · $41.9M federal (possible match)
- Spero Therapeutics, Inc. · 41 SEC filings in 12 months · 4 flags · $39.5M federal (possible match)
- Grifols SA · 18 SEC filings in 12 months · $22.5M federal (possible match)
- SCYNEXIS INC · 54 SEC filings in 12 months · 3 flags · $18.5M federal (possible match)
- Ensysce Biosciences, Inc. · 45 SEC filings in 12 months · 3 flags · $15.1M federal (possible match)
- UNITED THERAPEUTICS Corp · 454 SEC filings in 12 months · 2 flags · $6.8M federal (possible match)
- Zoetis Inc. · 144 SEC filings in 12 months · 1 flag · $6.7M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-04-16 filing 424B3 · SEC EDGAR
- 2025-03-27 filing F-6 POS · SEC EDGAR
- 2025-03-27 name change Name changed from Relief Therapeutics Holding SA · SEC EDGAR
- 2024-12-17 filing 424B3 · SEC EDGAR
- 2024-12-17 filing 15F-12G · SEC EDGAR
- 2024-12-16 filing 6-K · SEC EDGAR
- 2024-11-12 filing 6-K · SEC EDGAR
- 2024-11-05 filing 6-K · SEC EDGAR
- 2024-10-28 filing 6-K · SEC EDGAR
- 2024-10-22 filing 6-K · SEC EDGAR
- 2024-10-09 filing 6-K · SEC EDGAR
- 2024-10-07 filing 6-K · SEC EDGAR
- 2024-09-23 filing 6-K · SEC EDGAR
- 2024-09-19 filing 6-K · SEC EDGAR
- 2024-09-04 filing 6-K · SEC EDGAR
- 2024-08-30 filing 6-K · SEC EDGAR
- 2024-08-06 filing 6-K · SEC EDGAR
- 2024-06-28 filing 6-K · SEC EDGAR
- 2024-06-03 filing 6-K · SEC EDGAR
- 2024-05-10 filing 6-K · SEC EDGAR
- 2024-04-30 filing Annual report (20-F) · SEC EDGAR
- 2024-04-03 filing 6-K · SEC EDGAR
- 2024-03-27 filing 6-K · SEC EDGAR
- 2024-02-28 filing 6-K · SEC EDGAR
- 2023-12-05 filing 6-K · SEC EDGAR
- 2023-11-22 filing 6-K · SEC EDGAR
- 2023-10-10 filing 6-K · SEC EDGAR
- 2023-09-15 filing 6-K · SEC EDGAR
- 2023-08-31 filing 6-K · SEC EDGAR
- 2023-06-23 filing 6-K · SEC EDGAR
32 earlier entries
- 2023-06-20 filing 6-K
- 2023-06-01 filing 6-K
- 2023-05-12 filing Annual report (20-F)
- 2023-05-03 filing 6-K
- 2023-05-02 filing NT 20-F
- 2023-04-24 filing F-6 POS
- 2023-04-17 filing 6-K
- 2023-04-05 filing 6-K
- 2023-04-04 filing 6-K
- 2023-02-08 filing 6-K
- 2023-02-07 filing RW
- 2022-12-23 filing F-1/A
- 2022-11-15 filing F-1/A
- 2022-10-21 filing F-6 POS
- 2022-10-14 filing 6-K
- 2022-09-15 filing 6-K
- 2022-08-23 filing F-1
- 2022-08-04 filing 6-K
- 2022-08-01 filing F-6 POS
- 2022-07-20 filing SEC STAFF ACTION
- 2022-07-11 filing 20FR12G
- 2022-07-11 filing RW
- 2022-07-01 filing 20FR12B/A
- 2022-06-16 filing 20FR12B/A
- 2022-05-10 filing 20FR12B/A
- 2022-03-18 filing 20FR12B/A
- 2021-12-15 filing 20FR12B
- 2021-11-12 filing EFFECT
- 2021-11-03 filing F-6
- 2021-08-25 filing D
- 2021-03-30 filing D
- 2021-03-30 name change Name changed from Relief Therapeutics Holding AG
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-04-16 (older) 424B3 filed
- 2025-03-27 (older) F-6 POS filed (FORM F-6 POST EFFECTIVE AMENDMENT NO. 4 TO REGISTRATION STATEMENT)
- 2024-12-17 (older) 424B3 filed (RULE 424(B)(3) ADR)
- 2024-12-17 (older) 15F-12G filed (FORM 15-F NOTICE OF TERMINATION)
- 2024-12-16 (older) 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR DECEMBER, 2024)
- 2024-11-12 (older) 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 2024)
- 2024-11-05 (older) 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 2024)
- 2024-10-28 (older) 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 2024)
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-20; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- No listing symbol is held for this company.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
0 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 1854078 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | MMTZF / OTC, OTC | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | other | 2026-04-16 | SEC EDGAR company profile | as filed | 2026-11-20 14:09 UTC | Report an error |
| SIC industry | 2834 Pharmaceutical Preparations | 2026-04-16 | SEC EDGAR company profile | as filed | 2026-11-20 14:09 UTC | Report an error |
| State of incorporation | V8 | 2026-04-16 | SEC EDGAR company profile | as filed | 2026-11-20 14:09 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-04-16 | SEC EDGAR company profile | as filed | 2026-11-20 14:09 UTC | Report an error |
| Business address | AVENUE DE SECHERON 15, CH-1202 GENEVA | 2026-04-16 | SEC EDGAR company profile | as filed | 2026-11-20 14:09 UTC | Report an error |
| Exchanges | OTC, OTC | 2026-04-16 | SEC EDGAR company profile | as filed | 2026-11-20 14:09 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Form D total offering amount (D filed 2021-08-25) | $16,404,000 | 2021-08-25 | D | as filed | 2026-11-20 14:09 UTC | Report an error |
| Form D total amount sold (D filed 2021-08-25) | $16,404,000 | 2021-08-25 | D | as filed | 2026-11-20 14:09 UTC | Report an error |
| Form D industry group | Pharmaceuticals | 2021-08-25 | D | as filed | 2026-11-20 14:09 UTC | Report an error |
| Form D revenue range | $5,000,001 - $25,000,000 | 2021-08-25 | D | as filed | 2026-11-20 14:09 UTC | Report an error |
| Form D date of first sale | 2021-07-28 | 2021-08-25 | D | as filed | 2026-11-20 14:09 UTC | Report an error |
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-04-16 Filing 424B3 filed
- 2025-03-27 Filing F-6 POS filed (FORM F-6 POST EFFECTIVE AMENDMENT NO. 4 TO REGISTRATION STATEMENT)
- 2024-12-17 Filing 424B3 filed (RULE 424(B)(3) ADR)
- 2024-12-17 Filing 15F-12G filed (FORM 15-F NOTICE OF TERMINATION)
- 2024-12-16 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR DECEMBER, 2024)
- 2024-11-12 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 2024)
- 2024-11-05 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 2024)
- 2024-10-28 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 2024)
- 2024-10-22 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 2024)
- 2024-10-09 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 2024)
- 2024-10-07 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR OCTOBER, 2024)
- 2024-09-23 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR SEPTEMBER, 2024)
- 2024-09-19 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR SEPTEMBER, 2024)
- 2024-09-04 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR SEPTEMBER, 2024)
- 2024-08-30 Filing 6-K filed
- 2024-08-06 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR AUGUST, 2024)
- 2024-06-28 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR JUNE, 2024)
- 2024-06-03 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR JUNE, 2024)
- 2024-05-10 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR MAY, 2024)
- 2024-04-30 Filing 20-F filed
- 2024-04-03 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR APRIL, 2024)
- 2024-03-27 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR MARCH, 2024)
- 2024-02-28 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR FEBRUARY, 2024)
- 2023-12-05 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR DECEMBER, 2023)
- 2023-11-22 Filing 6-K filed (FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER FOR NOVEMBER, 2023)
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/1854078.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0001854078. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.